Session Details

F013 Challenging Skin Disorders of Hands and Feet

Fri, Mar 19, 1:00 PM - 3:00 PM
2 CME Available Forum

DESCRIPTION

Hands and feet skin disorders have a huge impact on quality of life and are often a diagnostic and therapeutic challenge. This session will review clinical presentation, management and treatment of challenging hand and foot disorders including psoriasis, palmoplantar pustulosis, vitiligo, chronic hand eczema, recurrent actinic keratoses and peri-ungual warts. Recent developments in etiopathogenesis and challenging diagnoses of skin disorders involving hands and feet will also be reviewed and discussed.

LEARNING OBJECTIVES

1.

Manage challenging cases of skin diseases involving hands and feet.

2.

Select the best treatment options for vitiligo, psoriasis, pustulosis, eczema, periungual warts and actinic keratoses affecting hands and/or feet.

SCHEDULE

1:00 PM

Hand and Foot Eczema: Recent Advances on Etiopathogenesis

Emma Guttman, MD, PhD, FAAD

1:17 PM

Treatment of Hand and Foot Eczema

Robert Bissonnette, MSc, MD, FAAD

1:34 PM

Treatment of Palmoplantar Psoriasis

Bruce Elliot Strober, MD, PhD, FAAD

1:51 PM

Palmoplantar Pustulosis: Workup and Treatment

Thierry Passeron, MD, PhD

2:08 PM

Hand Vitiligo: A Therapeutic Challenge

Iltefat H. Hamzavi, MD, FAAD

2:25 PM

Treatment Options for Recalcitrant Periungual Warts

Kendall Billick, MD, FAAD

2:42 PM

Treatment of Recurrent Actinic Keratoses on the Back of Hands

Rolf-Markus Szeimies, MD, PhD, IFAAD

DIRECTOR

Robert Bissonnette, MSc, MD, FAAD

Robert Bissonnette, MSc, MD, FAAD

Indero

SPEAKERS

Kendall Billick, MD, FAAD

Kendall Billick, MD, FAAD

Emma Guttman, MD, PhD, FAAD

Emma Guttman, MD, PhD, FAAD

Icahn School of Medicine at Mount Sinai, New York

Iltefat H. Hamzavi, MD, FAAD

Iltefat H. Hamzavi, MD, FAAD

Thierry Passeron, MD, PhD

Thierry Passeron, MD, PhD

Bruce Elliot Strober, MD, PhD, FAAD

Bruce Elliot Strober, MD, PhD, FAAD

Rolf-Markus Szeimies, MD, PhD, IFAAD

Rolf-Markus Szeimies, MD, PhD, IFAAD

DISCLOSURES

Kendall Billick, MD, FAAD

No financial relationships exist with ineligible companies.

Robert Bissonnette, MSc, MD, FAAD

AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Aldena Therapeutics – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Honoraria), Other(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Amgen – Consultant(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria), Other(Grants/Research Funding); Apollo Therapeutics Ltd – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Attovia Therapeutics – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Bluefin Biomedicine – Other(Grants/Research Funding); BMS – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Enveda Biosciences – Other(Grants/Research Funding); GSK – Consultant (1099 relationship)(Honoraria), Other(Grants/Research Funding); Horizon Therapeutics Ireland DAC – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Indero – Stockholder Private Company(Stock); Inmagene Biopharmaceuticals – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Janssen Scientific Affairs, LLC – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Nektar Therapeutics – Other(Grants/Research Funding); Odyssey Therapeutics – Other(Grants/Research Funding); opsidio – Investigator(Grants/Research Funding); Opsidio – Other(Grants/Research Funding); Organon – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Other(Grants/Research Funding); Pelage Pharmaceuticals – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Q32 Bio Inc. – Other(Grants/Research Funding); Recludix Pharma – Other(Grants/Research Funding); Sanofi – Other(Grants/Research Funding); Sanofi Aventis – Consultant(Honoraria); Sanofi Genzyme – Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Other(Grants/Research Funding); Shattuck Labs – Other(Grants/Research Funding); Sitryx – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); T-Rex BioPharma – Consultant (1099 relationship)(Honoraria); Takeda Development Center Americas, Inc. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); TARGET Pharma – Investigator(Grants/Research Funding); Triveni Bio – Other(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VYNE Therapeutics – Other(Grants/Research Funding); Xencor – Investigator(Grants/Research Funding), Other(Grants/Research Funding); Zenas Biopharma – Other(Grants/Research Funding); Zura Bio – Other(Grants/Research Funding);

Emma Guttman, MD, PhD, FAAD

AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Fees); Biolojic Design – Consultant (1099 relationship)(Fees); Bionyra Pharma – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celldex – Consultant (1099 relationship)(Fees); Cue Biopharma – Consultant (1099 relationship)(Fees); CytoReason – Consultant (1099 relationship)(Fees); DBV Technologies – Consultant (1099 relationship)(Fees); Dualitas Therapeutics – Consultant (1099 relationship)(Fees); Electra Therapeutics – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Generate Biomedicines – Consultant (1099 relationship)(Fees); Gilead Sciences, Inc – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Infimmune – Consultant (1099 relationship)(Fees); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); Kymera Therapeutics – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Matchpoint Therapeutics – Consultant (1099 relationship)(Fees); Merck – Consultant(Fees), Consultant(Honoraria); Navigator Medicines – Consultant (1099 relationship)(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Opsidio – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Propeller Bio – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Consultant (1099 relationship)(Stock Options), Investigator(Grants/Research Funding); RayThera – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Rubedo Life Sciences – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees); Sitryx – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); TRex Bio – Consultant (1099 relationship)(Fees); Triveni Bio – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Ventyx Biosciences – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VRG Therapeutics – Consultant (1099 relationship)(Fees); Xencor – Consultant (1099 relationship)(Fees);

Iltefat H. Hamzavi, MD, FAAD

AbbVie – Advisory Board(Fees); Almirall – Consultant (1099 relationship)(Fees); Avita – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Advisory Board(Fees); Boehringer Ingelheim – Consultant(Fees); Clinuvel – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Lenicura – Investigator(Equipment); Merck – Investigator(Grants/Research Funding); MyDerm Portal, Inc – Stockholder(Stock); Novartis – Consultant(Fees); Pfizer Inc. – Investigator(Fees); Sonoma Biotherapeutics – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Teva Pharmaceutical Industries Ltd. – Investigator(Fees); UCB – Consultant(Fees); Vimela – Consultant (1099 relationship)(Fees);

Thierry Passeron, MD, PhD

AbbVie – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Almirall – Advisory Board(Honoraria); Amgen – Consultant(Honoraria); Astellas Pharma US, Inc – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Speaker(Honoraria); Bioderma – Speaker/Faculty Education(Honoraria); Celgene Corporation – Investigator(Grants/Research Funding); Cutera, Inc. – Advisory Board(Honoraria); Galderma Research & Development, LLC – Advisory Board(Honoraria); GlaxoSmithKline – Speaker/Faculty Education(Honoraria); Hyphens Pharma – Speaker/Faculty Education(Honoraria); Incyte Corporation – Investigator(Fees), Speaker/Faculty Education(Honoraria); ISDIN – Advisory Board(Honoraria), Speaker(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Journal of the European Academy of Dermatology and Venereology – Other(No Compensation Received); L'Oréal Research and Innovation – Speaker/Faculty Education(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(Honoraria); Leo Pharma Inc. – Speaker/Faculty Education(Honoraria); Lilly ICOS LLC – Speaker/Faculty Education(Honoraria); Mesoestetic USA Laboratories – Advisory Board(Honoraria); MSD – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker/Faculty Education(Honoraria); Symrise – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Vichy Laboratoires – Advisory Board(Honoraria), Speaker(Honoraria); VYNE Therapeutics – Advisory Board(Honoraria);

Bruce Elliot Strober, MD, PhD, FAAD

AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Johnson and Johnson – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria);

Rolf-Markus Szeimies, MD, PhD, IFAAD

AbbVie – Speaker(Honoraria); Almirall – Advisory Board(Honoraria), Speaker(Honoraria); Beiersdorf, Inc. – Advisory Board(Fees); Biofrontera AG – Investigator(Fees), Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Speaker(Honoraria); Kurt Wolff GmbH & Co. KG – Advisory Board(Fees), Investigator(Fees); Leo Pharma A/S – Advisory Board(Honoraria), Investigator(Fees); Springer Publishing – Advisory Board(Honoraria);